Gland Pharma Limited

Informe acción NSEI:GLAND

Capitalización de mercado: ₹277.8b

Salud financiera de hoja de balance de Gland Pharma

Salud financiera controles de criterios 5/6

Gland Pharma tiene un patrimonio de accionistas total de ₹83.1B y una deuda total de ₹3.6B, lo que sitúa su ratio deuda-patrimonio en 4.3%. Sus activos y pasivos totales son ₹102.9B y ₹19.9B respectivamente. El BAIT de Gland Pharma es de ₹8.6B, por lo que su ratio de cobertura de intereses es de -5.3. Tiene efectivo e inversiones a corto plazo que ascienden a ₹21.4B.

Información clave

4.3%

Ratio deuda-patrimonio

₹3.57b

Deuda

Ratio de cobertura de intereses-5.3x
Efectivo₹21.45b
Patrimonio₹83.07b
Total pasivo₹19.86b
Activos totales₹102.93b

Actualizaciones recientes sobre salud financiera

Recent updates

Is Gland Pharma (NSE:GLAND) A Risky Investment?

Mar 19
Is Gland Pharma (NSE:GLAND) A Risky Investment?

Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Feb 16
Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

May 20
Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07
Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Jul 22
Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Jul 14
Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Feb 08
Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Jul 05
A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

May 24
Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

May 19
Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Mar 04
Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 20
Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹59.7B) de GLAND superan a sus pasivos a corto plazo (₹15.4B).

Pasivo a largo plazo: Los activos a corto plazo de GLAND (₹59.7B) superan a sus pasivos a largo plazo (₹4.5B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: GLAND tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de GLAND ha crecido de 0.2% a 4.3% en los últimos 5 años.

Cobertura de la deuda: La deuda de GLAND está bien cubierta por el flujo de caja operativo (109.3%).

Cobertura de intereses: GLAND gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera